Bioventix Company Description

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment.

It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results.

Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Bioventix PLC

Country	United Kingdom
Founded	2003
Industry	Biotechnology
Sector	Healthcare
Employees	17
CEO	Peter Harrison

Contact Details

Address: 7 Romans Business Park Farnham, GU9 7SX United Kingdom
Phone	44 12 5272 8001
Website	bioventix.com

Stock Details

Ticker Symbol	BVXP
Exchange	London Stock Exchange AIM
Fiscal Year	July - June
Reporting Currency	GBP
ISIN Number	GB00B4QVDF07
SIC Code	2836

Key Executives

Name	Position
Peter Harrison	Chief Executive Officer
Bruce Edward Hiscock	Chief Financial Officer